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LETIERS TO THE EDITOR 
Off-pump internal thoracic artery-left anterior 
descending coronary artery grafting via small anterior 
thoracotomy: When and compared to what? 
To the Editor: 
We read with interest the article by Calafiore and associates 
on the midterm results after minimally invasive coronary 
surgery (J Thorac Cardiovasc Surg 1998;115:763-71). 
The authors deserve credit for having popularized grafting 
of the left internal thoracic artery (ITA) to the left anterior 
descending coronary artery (LAD). There is some concern, 
however, about patient selection and patient mix in the study 
population, on which the analyses in the paper are based. It is 
uncommon to find an indication for single LAD grafting in 
patients with multiple-vessel disease. Indeed, on page 764 the 
authors state that patients who are eligible for such an opera-
tion form a "very select" group of all patients having multiple-
vessel disease. It is therefore surprising that the authors man-
aged to find 220 patients of this rare category selected for 
their study, an even larger group than the single-LAD group 
(214 patients). The total number of patients who underwent 
coronary artery bypass grafting in that period was not men-
tioned. Also, there may have been some special referrals. 
More important, in the presentation of the results the two 
groups are largely combined. 
This makes generalization of the results questionable. The 
extraordinary nature of this large group of patients with mul-
tiple-vessel disease, treated with single-LAD grafting, is illus-
trated by the apparent absence of a material difference in 
functional outcome. It should be noted, however, that this per-
tains to midterm outcome only. Differences in outcome may 
well become visible on long-term follow-up. 
The authors should consider presenting their data strictly 
separately for single- and multiple-vessel groups. The multi-
ple-vessel group in the present study should be regarded with 
caution, because this necessarily is a highly atypical group of 
patients. If not, the findings challenge the basic concept of 
surgical myocardial revascularization, that is, complete revas-
cularization. Still, the long-term follow-up of this atypical 
group is of clear interest. In its present form the results of the 
report are difficult to interpret and may lead to confusion. 
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Reply to the Editor: 
The relatively high number of patients with multiple-vessel 
disease in the population that underwent single LAD grafting 
described in our recent article (J Thorac Cardiovasc Surg 
1998;115:763-71) disturbed more than one surgeon. The idea 
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Fig 1. Coronary angiogram showing a severely diseased 
LAD. The huge marginal branch is free of significant lesions, 
but the distal circumflex artery shows a severe stenosis fol-
lowed by a small terminal branch. 
to leave a diseased coronary vessel ungrafted seems to be a 
strategic mistake. 
However, the inclusion of this "very select group" of 
patients depends on the definition of "diseased vessel" and of 
"complete revascularization." 
My definition of "diseased vessel" is the following: A ves-
sel is considered "diseased" if it is the main vessel of the ter-
ritory or if a side branch of it is occluded or if it has a lesion 
equal to or greater than 70%. If a circumflex artery or a right 
coronary artery has a short and small posterolateral branch 
with such lesions, the circumflex artery or the right coronary 
artery has to be defined as "diseased." In Fig 1, a coronary 
angiogram is shown in which the LAD has severe disease; the 
huge marginal branch is free of significant lesions, but the dis-
tal circumflex artery shows a severe stenosis followed by a 
small terminal branch. This patient has 2-vessel disease, but I 
would never graft this small branch which, in my opinion, has 
no influence on the patient's future. I certainly would never 
use cardiopulmonary bypass for such a purpose. 
The concept of "complete revascularization" needs a more 
thorough analysis. If with this term we mean that any lesion 
that causes ischemia to the patient should be grafted, I fully 
agree. If this definition also includes the necessity to graft 
major and important coronary vessels supplying a huge terri-
tory and with a significant (~70%) lesion, even if there is no 
clearly demonstrated ischemia, when concomitant grafting to 
other surely ischemic territories is performed, I fully agree. 
